|
C2ORF29 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.738400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.792300E-02 |
| Normal-vs-Stage2 |
1.599180E-01 |
| Normal-vs-Stage3 |
4.800600E-03 |
| Normal-vs-Stage4 |
9.389400E-04 |
| Stage1-vs-Stage2 |
9.908600E-01 |
| Stage1-vs-Stage3 |
1.673980E-01 |
| Stage1-vs-Stage4 |
5.412200E-02 |
| Stage2-vs-Stage3 |
3.748600E-01 |
| Stage2-vs-Stage4 |
1.347030E-01 |
| Stage3-vs-Stage4 |
4.473000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.003570E-02 |
| Normal-vs-AfricanAmerican |
7.554000E-02 |
| Normal-vs-Asian |
3.403200E-01 |
| Caucasian-vs-AfricanAmerican |
8.505600E-01 |
| Caucasian-vs-Asian |
3.196200E-01 |
| AfricanAmerican-vs-Asian |
3.869400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.084300E-03 |
| Normal-vs-Female |
1.364210E-02 |
| Male-vs-Female |
4.380400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.687800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.237600E-03 |
| Normal-vs-Age(61-80Yrs) |
6.401900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.309000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.304200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.340200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.108200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.471600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.025200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.889200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.473600E-01 |
| Classical-VS-Follicular |
1.638760E-03 |
| Classical-VS-Other |
1.396570E-01 |
| Classical-VS-Normal |
1.922180E-01 |
| Tall-VS-Follicular |
4.554200E-01 |
| Tall-VS-Other |
4.645800E-01 |
| Tall-VS-Normal |
5.718000E-02 |
| Follicular-VS-Other |
7.365200E-01 |
| Follicular-VS-Normal |
7.173300E-04 |
| Other-VS-Normal |
3.504500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.615300E-03 |
| Normal-vs-N1 |
7.173600E-04 |
| N0-vs-N1 |
1.025410E-01 |
|
|
